CARE Network Maintenance Versus Intermittent Inhaled Steroids in Wheezing Toddlers (MIST)
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
Asthma affects about 4 million children in the United States and is a leading cause of
hospitalizations and school absenteeism. Continuous wheezing in very young children may
develop into asthma. Low doses of inhaled corticosteroids (ICS) are commonly prescribed to
treat children with particularly bad wheezing episodes. This study will compare the safety
and effectiveness of low doses of ICS taken daily versus higher doses of ICS taken only
during respiratory tract illnesses for toddlers with continuous wheezing or coughing
illnesses.